XMEX:ABT Abbott Laboratories Insider Activity 4 Filing - 3/22/2012

Effective Date 3/22/2012

XMEX:ABT (Abbott Laboratories): Fair Value Estimate
Premium
XMEX:ABT (Abbott Laboratories): Consider Buying
Premium
XMEX:ABT (Abbott Laboratories): Consider Selling
Premium
XMEX:ABT (Abbott Laboratories): Fair Value Uncertainty
Premium
XMEX:ABT (Abbott Laboratories): Economic Moat
Premium
XMEX:ABT (Abbott Laboratories): Stewardship
Premium
 
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Fussell Stephen R
  2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ABT]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Senior Vice President
(Last)
(First)
(Middle)
100 ABBOTT PARK ROAD
3. Date of Earliest Transaction (Month/Day/Year)
03/22/2012
(Street)

ABBOTT PARK, IL 60064-6400
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common shares without par value 03/22/2012   M   1,525 A $33.2314 101,925 D  
Common shares without par value 03/22/2012   M   5,818 A $47.82 107,743 D  
Common shares without par value 03/22/2012   F   5,948 D $60.39 101,795 D  
Common shares without par value               999(1) I Profit Sharing Trust
Common shares without par value               53(2) I By spouse

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy)(3) $33.2314 03/22/2012   M     1,525 02/14/2006 02/13/2013 Common shares 1,525 $ 0 0 D  
Option (right to buy)(3) $47.82 03/22/2012   M     5,818 02/01/2007 02/13/2013 Common shares 5,818 $ 0 0 D  
Option (right to buy)(3) $60.39 03/22/2012   A   5,948   09/23/2012 02/13/2013 Common shares 5,948 $ 0 5,948 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Fussell Stephen R
100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064-6400
      Senior Vice President  

Signatures

 John A. Berry, by power of attorney for Stephen R. Fussell   03/23/2012
** Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Balance in the Abbott Laboratories Stock Retirement Trust as of March 21, 2012.
(2) The reporting person disclaims beneficial ownership of all securities held by his spouse.
(3) Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

XMEX:ABT Abbott Laboratories Insider Activity 4 Filling

Abbott Laboratories XMEX:ABT Stock - Get Insider Activity SEC Filing of Abbott Laboratories XMEX:ABT stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

XMEX:ABT Abbott Laboratories Insider Activity 4 Filing - 3/22/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: XMEX:ABT Abbott Laboratories Insider Activity 4 Filing - 3/20/2012  |  Next: XMEX:ABT Abbott Laboratories Insider Activity 4 Filing - 3/22/2012